Healthcare Sales & Marketing Network News: frovatriptan

Searching News Database: frovatriptan

HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch

HSMN NewsFeed - 12 May 2016
Mylan Launches Generic Frova(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 6 Jan 2016
Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jul 2006
Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Menstrual Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Biopharmaceuticals

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
frovatriptan
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.